Acadia Healthcare (NASDAQ:ACHC) PT Lowered to $91.00 at Barclays

Acadia Healthcare (NASDAQ:ACHC) had its price target cut by Barclays from $100.00 to $91.00 in a research note published on Thursday morning, Benzinga reports. They currently have an overweight rating on the stock.

A number of other analysts have also recently weighed in on the company. TheStreet upgraded Acadia Healthcare from a c rating to a b- rating in a research report on Monday, March 4th. UBS Group boosted their target price on Acadia Healthcare from $88.00 to $102.00 and gave the stock a buy rating in a report on Wednesday, February 28th. Stephens raised Acadia Healthcare from an equal weight rating to an overweight rating and set a $92.00 price target for the company in a report on Friday, January 5th. TD Cowen boosted their price objective on Acadia Healthcare from $86.00 to $101.00 and gave the stock an outperform rating in a research note on Friday, March 1st. Finally, Royal Bank of Canada restated an outperform rating and issued a $94.00 target price on shares of Acadia Healthcare in a research note on Monday, March 4th. One analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of Moderate Buy and an average target price of $88.89.

Acadia Healthcare Stock Down 0.9 %

ACHC stock opened at $66.12 on Thursday. The business’s 50-day simple moving average is $76.77 and its 200 day simple moving average is $77.52. The company has a quick ratio of 0.67, a current ratio of 1.27 and a debt-to-equity ratio of 0.63. The company has a market cap of $6.11 billion, a PE ratio of -472.25, a price-to-earnings-growth ratio of 1.95 and a beta of 1.31. Acadia Healthcare has a twelve month low of $64.74 and a twelve month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, May 1st. The company reported $0.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.04. The business had revenue of $768.10 million for the quarter, compared to analysts’ expectations of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. Acadia Healthcare’s quarterly revenue was up 9.1% on a year-over-year basis. During the same period in the previous year, the business posted $0.75 earnings per share. On average, research analysts anticipate that Acadia Healthcare will post 3.56 earnings per share for the current year.

Insider Activity

In other news, Director Wade D. Miquelon sold 2,203 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.00% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Quent Capital LLC increased its stake in shares of Acadia Healthcare by 8.1% in the 1st quarter. Quent Capital LLC now owns 3,784 shares of the company’s stock valued at $300,000 after acquiring an additional 284 shares during the last quarter. BNP Paribas Financial Markets grew its holdings in Acadia Healthcare by 77.1% during the first quarter. BNP Paribas Financial Markets now owns 21,453 shares of the company’s stock valued at $1,700,000 after purchasing an additional 9,342 shares during the period. Peterson Wealth Services bought a new stake in Acadia Healthcare in the first quarter valued at approximately $2,739,000. Retirement Systems of Alabama raised its holdings in Acadia Healthcare by 0.3% in the first quarter. Retirement Systems of Alabama now owns 115,799 shares of the company’s stock worth $9,174,000 after purchasing an additional 303 shares during the period. Finally, OFI Invest Asset Management boosted its position in shares of Acadia Healthcare by 2.5% during the first quarter. OFI Invest Asset Management now owns 164,427 shares of the company’s stock worth $12,061,000 after purchasing an additional 4,013 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.